This week, there are 6 drugs in the patent and exclusivity list. They are: - NOVARTIS PHARMACEUTICALS CORP's TAFINLAR, containing active ingredient DABRAFENIB MESYLATE - NOVARTIS PHARMACEUTICALS CORP's MEKINIST, containing active ingredient TRAMETINIB DIMETHYL SULFOXIDE - COLLEGIUM PHARMACEUTICAL INC's XTAMPZA ER, containing active ingredient OXYCODONE - ELI LILLY AND CO's OLUMIANT, containing active ingredient BARICITINIB - MEDICINES DEVELOPMENT FOR GLOBAL HEALTH's MOXIDECTIN, containing active ingredient MOXIDECTIN - JAZZ PHARMACEUTICALS IRELAND LTD's ZEPZELCA, containing active ingredient LURBINECTEDIN Read More

This week, there are 5 drugs in the patent and exclusivity list. They are: - PARATEK PHARMACEUTICALS INC's NUZYRA, containing active ingredient OMADACYCLINE TOSYLATE - SANDOZ INC's CIPRODEX, containing active ingredient CIPROFLOXACIN; DEXAMETHASONE - BRAEBURN INC's BRIXADI, containing active ingredient BUPRENORPHINE - INSMED INC's ARIKAYCE KIT, containing active ingredient AMIKACIN SULFATE - ABBVIE INC's VENCLEXTA, containing active ingredient VENETOCLAX Read More

Query Drug：TirzepatideQuery Time：2025-05-29 16:35:52*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Read More

This week, there are 11 drugs in the patent and exclusivity list. They are: - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's SPIRIVA RESPIMAT, containing active ingredient TIOTROPIUM BROMIDE - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's COMBIVENT RESPIMAT, containing active ingredient ALBUTEROL SULFATE; IPRATROPIUM BROMIDE - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's STIOLTO RESPIMAT, containing active ingredient OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's STRIVERDI RESPIMAT, containing active ingredient OLODATEROL HYDROCHLORIDE - ALNYLAM PHARMACEUTICALS INC's ONPATTRO, containing active ingredient PATISIRAN SODIUM - ACROTECH BIOPHARMA INC's FOLOTYN, containing active ingredient PRALATREXATE - SUN PHARMACEUTICAL INDUSTRIES LTD's WINLEVI, containing active ingredient CLASCOTERONE - SALIX PHARMACEUTICALS INC's XIFAXAN, containing active ingredient RIFAXIMIN - FRESENIUS KABI USA LLC's DIPRIVAN, containing active ingredient PROPOFOL Read More

This week, there are 15 drugs in the patent and exclusivity list. They are: - TEVA PHARMACEUTICAL INDUSTRIES LTD's AIRDUO RESPICLICK, containing active ingredient FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC's PROAIR RESPICLICK, containing active ingredient ALBUTEROL SULFATE - GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND's TRELEGY ELLIPTA, containing active ingredient FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE - GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE's BREO ELLIPTA, containing active ingredient FLUTICASONE FUROATE; VILANTEROL TRIFENATATE - GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND's ANORO ELLIPTA, containing active ingredient UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE - AZURITY PHARMACEUTICALS INC's EDARBYCLOR, containing active ingredient AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE Read More

This week, there are 9 drugs in the patent and exclusivity list. They are: - GILEAD SCIENCES INC's ZYDELIG, containing active ingredient IDELALISIB - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's STRIVERDI RESPIMAT, containing active ingredient OLODATEROL HYDROCHLORIDE - CARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES 's LYMPHOSEEK KIT, containing active ingredient TECHNETIUM TC-99M TILMANOCEPT - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's STIOLTO RESPIMAT, containing active ingredient OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE - JANSSEN PHARMACEUTICALS INC's XARELTO, containing active ingredient RIVAROXABAN - CORMEDIX INC's DEFENCATH, containing active ingredient HEPARIN SODIUM; TAUROLIDINE - BIOMARIN PHARMACEUTICAL INC's KUVAN, containing active ingredient SAPROPTERIN DIHYDROCHLORIDE - MITSUBISHI TANABE PHARMA CORP's RADICAVA ORS, containing active ingredient EDARAVONE - DECIPHERA PHARMACEUTICALS LLC's QINLOCK, containing active ingredient RIPRETINIB Read More

This week, there are 9 drugs in the patent and exclusivity list. They are: - PFIZER INC's VIZIMPRO, containing active ingredient DACOMITINIB - SUMITOMO PHARMA AMERICA INC's APTIOM, containing active ingredient ESLICARBAZEPINE ACETATE - ASTRAZENECA LP's SYMBICORT, containing active ingredient BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - NEURELIS INC's VALTOCO, containing active ingredient DIAZEPAM - NOVARTIS PHARMACEUTICAL CORP's TABRECTA, containing active ingredient CAPMATINIB HYDROCHLORIDE - ELI LILLY AND CO's RETEVMO, containing active ingredient SELPERCATINIB - BRISTOL MYERS SQUIBB CO's SPRYCEL, containing active ingredient DASATINIB - ASTRAZENECA PHARMACEUTICALS LP's BRILINTA, containing active ingredient TICAGRELOR - ELI LILLY AND CO's OLUMIANT, containing active ingredient BARICITINIB Read More

Query Drug：OlaparibQuery Time：2025-03-10 13:13:19*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Read More

This week, there are 16 drugs in the patent and exclusivity list. They are: - PF PRISM CV's INLYTA, containing active ingredient AXITINIB - KALEO INC's AUVI-Q, containing active ingredient EPINEPHRINE - ASTRAZENECA PHARMACEUTICALS LP's BRILINTA, containing active ingredient TICAGRELOR - IPSEN BIOPHARMACEUTICALS INC's ONIVYDE, containing active ingredient IRINOTECAN HYDROCHLORIDE - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's JENTADUETO, containing active ingredient LINAGLIPTIN; METFORMIN HYDROCHLORIDE - BOEHRINGER INGELHEIM's GLYXAMBI, containing active ingredient EMPAGLIFLOZIN; LINAGLIPTIN - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's TRIJARDY XR, containing active ingredient EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's TRADJENTA, containing active ingredient LINAGLIPTIN - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's JENTADUETO XR, containing active ingredient LINAGLIPTIN; METFORMIN HYDROCHLORIDE Read More